Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Caucasian Men and Women aged 20 to 65
Age20 - 65
Payment£2180 plus 2 travel payments
Study DatesAug. 21 - Oct. 06, 2022
This study involves one 8 night stay, with one outpatient visit and one or two follow up calls.
This study is available to Caucasian men and women aged 20-65 with a BMI between 18 and 30. Volunteers are allowed to be smokers, but must agree to refrain from smoking from 1 week prior to screening and check-in until after dosing. Gilberts syndrome is not acceptable. HRT is acceptable. There is a vegetarian menu available on this study.
Detailed Study Dates
Check in: 21 Aug 2022 Check out: 29 Aug 2022
Outpatient visit: 31 Aug 2022
Follow up call: 07 Sep 2022
***Follow up call: 06 Oct 2022 (females only)
Check in: 11 Sep 2022 Check out: 19 Sep 2022
Outpatient visit: 21 Sep 2022
Follow up call: 28 Sep 2022
***Follow up call: 27 Oct 2022 (females only)